Welcome to our dedicated page for BIOLARGO news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on BIOLARGO stock.
BioLargo, Inc. (BLGO) focuses on delivering sustainable technology-based products to address critical issues in water, food, agriculture, healthcare, and energy sectors. The company's subsidiary, BioLargo Water, Inc., is known for its advanced oxidation systems, including the AOS filter, designed to efficiently eliminate toxic contaminants in water. BioLargo has received the Technology Star Award for its breakthrough innovation in the oil industry and recognized as a technology innovation leader in the water treatment market. Additionally, the company owns a 50% interest in the Isan System, which has been honored as a top 50 water company for the 21st century.
BioLargo, Inc. (OTCQB:BLGO) has entered a channel partnership agreement with Product Recovery Management (PRM), based in Butner, NC, to distribute BioLargo's water treatment systems and serve as a contract manufacturer. PRM will sell and distribute innovative technologies such as the Aqueous Electrostatic Concentrator (AEC) and Advanced Oxidation System (AOS), focusing on PFAS contamination solutions. This collaboration aims to leverage PRM's manufacturing capabilities and expertise in environmental remediation to meet growing demand for effective water treatment solutions.
BioLargo, Inc. (OTCQB:BLGO) reported strong growth in its quarterly report for Q2 2022, with consolidated revenue reaching $1.32 million, marking a 185% increase year-over-year. The company's subsidiaries, ONM Environmental and BioLargo Engineering, recorded significant revenue gains and returned to net operating income. BioLargo secured its first PFAS client, expanding its commercial reach, particularly with its white-label pet odor control product, POOPH. Upcoming projects with Garratt-Callahan and continuing engineering initiatives indicate a positive outlook.
BioLargo, Inc. (OTCQB:BLGO) will hold a public investor webcast and conference call on August 17, 2022, at 1:00 PM Pacific / 4:00 PM Eastern. The session aims to discuss the company's financial results for the six months ending June 30, 2022, review recent milestones, and engage in a Q&A. Interested participants can access the webcast via a provided link and join the teleconference using specified numbers. The event also serves to highlight BioLargo's innovative solutions in environmental technology.
BioLargo, Inc. (OTCQB:BLGO) has announced securing its first customer for a PFAS mitigation plan and establishing a partnership to market its PFAS treatment equipment. The customer contract marks the beginning of a multi-phase project aimed at addressing per- and polyfluoroalkyl substances (PFAS), which are harmful chemicals affecting health and the environment. The new channel partner will aid in distributing the company's engineering services and treatment technologies, including the proprietary Aqueous Electrostatic Concentrator (AEC).
BioLargo, Inc. (OTCQB:BLGO) reported approximately $1.3 million in revenue for Q2 2022, a 37% increase from Q1 and a 185% increase compared to Q2 2021. The company attributes this growth to expanding sales of the POOPH product, the anticipated launch of PFAS treatment technology, and larger engineering projects. The revenue figures are preliminary and may change pending accounting review. Full results will be available in the quarterly report due by August 15, 2022. An investor webcast will follow the report's release.
BioLargo, Inc. (OTCQB:BLGO) announced that its Oak Ridge, Tennessee engineering subsidiary is partnering with Ultra Safe Nuclear to develop prototype fuel production systems for the innovative Micro Modular Reactor (MMR®). This revolutionary reactor technology utilizes Fully Ceramic Micro-encapsulated (FCM®) nuclear fuel, known for its high temperature stability. Ultra Safe Nuclear is investing around $13 million into its Oak Ridge facility, while BioLargo has secured contracts worth approximately $500,000. The companies aim to advance clean nuclear energy solutions.
BioLargo, Inc. (OTCQB: BLGO) will host an investor webcast on May 19, 2022, at 1:00 PM PT to discuss Q1 financial results, recent milestones, and future projects. This public event allows for audience interaction during a Q&A session. Participants can access the webcast via a provided link and will have the opportunity to listen to a replay afterward. BioLargo focuses on cleantech solutions including environmental engineering and has developed numerous innovative technologies, holding numerous patents and grants.
BioLargo, Inc. (OTCQB:BLGO) reported a record revenue of $965,000 for Q1 2022, a 69% increase from the previous year. Its subsidiary, ONM Environmental, achieved its first profitable quarter with $598,000 in revenue and a $13,000 operating profit. The Engineering division generated $355,000, significantly improving from a $183,000 loss last year. BioLargo is developing innovative solutions for PFAS contamination and progressing partnerships in private-label products and water treatment, aiming for substantial future revenue growth and positive cash flow.
BioLargo, Inc. (OTCQB:BLGO) reported a quarterly revenue record of approximately $900,000 for Q1 2022, marking a 60% increase from Q1 2021. The company's subsidiaries, ONM Environmental and BioLargo Engineering, contributed $550,000 and $350,000 to this revenue, respectively. Additionally, BioLargo Engineering has been awarded a feasibility contract for a waste-to-energy conversion plant in South America, potentially worth over $500 million. This project could engage BioLargo for the next four years, supporting its growth strategy in sustainable technology.
BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast and conference call on April 4, 2022, at 1:30 pm PT to discuss year-end financial results and recent commercial milestones. The public can participate through a webcast or teleconference. The event aims to enhance investor relations by providing insights into the company’s performance and future plans. A replay will be available until April 18, 2022, for the teleconference, and until April 4, 2023, for the webcast. BioLargo specializes in innovative technologies for environmental challenges.
FAQ
What is the current stock price of BIOLARGO (BLGO)?
What is the market cap of BIOLARGO (BLGO)?
What does BioLargo, Inc. focus on?
What is BioLargo Water, Inc. known for?
What awards has BioLargo received?
What is Isan System?
